Vortex speeds cancer drug discovery
1 October 2012Tweet
One of the world’s foremost cancer research establishments, The Institute of Cancer Research in London, has deployed Dotmatics’ data visualisation and analysis tool Vortex to help discover and develop new cancer drugs.
Vortex is designed specifically for analysis and interrogation of scientific data, providing users with an out-of-the-box filtering, charting, plotting, and chemically aware calculations engine. Scientists can evaluate large datasets in a rich, intuitive and flexible user interface. The use of Vortex helps uncover hidden data trends and correlations and identify potential drug candidates.
After rigorous internal testing, The Institute of Cancer Research (ICR) selected Vortex because of its ‘flexibility, ease of use and swift integration with our existing chemoinformatics data storage platform', said Professor Julian Blagg, head of chemistry and deputy director of the division of cancer therapeutics at The Institute of Cancer Research. ‘It allows the visualisation of multidimensional datasets on compounds of interest to study trends, relationships and to discover outliers,’ he added.
Dotmatics, based in Bishops Stortford south of Cambridge, UK, is a scientific software company deploying web-based knowledge solutions that improve the way scientific data is queried, managed and shared within companies. Dotmatics has significant expertise in cheminformatics and bioinformatics techniques including chemical databases, SAR analysis, data management and data visualisation.